Education
About Us
Working with TipRanks
Follow Us
Eddie Williams Insider Profile
4 Followers
Eddie Williams, Director at Gyre Therapeutics, holds 36.70K shares in BioAtla (Ticker: BCAB), holds 34.80K shares in Gyre Therapeutics (Ticker: GYRE), holds ― shares in BiomX (Ticker: PHGE).
Eddie Williams has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Eddie Williams holds in companies
Most Profitable Insider Trade
The most profitable trade made by Eddie Williams
Eddie Williams's Trading History
Gyre Therapeutics
Jan 07, 2022
Director
Uninformative Buy
―
$359.18K
BioAtla
Jun 14, 2024
Director
Uninformative Buy
―
$12.62K
BiomX
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Eddie Williams's performance on stock
You May Also Like
Eddie Williams insider profile FAQ
What is the percentage of profitable transactions made by Eddie Williams?
The percentage of profitable transactions made by Eddie Williams is ―.
What is the average return per transaction made by Eddie Williams?
The average return per transaction made by Eddie Williams is ―.
What stocks does Eddie Williams hold?
Eddie Williams holds: GYRE, BCAB, PHGE stocks.
What was Eddie Williams’s latest transaction?
Eddie Williams latest transaction was an Uninformative Buy of ―.
What was Eddie Williams's most profitable transaction?
Eddie Williams’s most profitable transaction was an Informative Buy of GYRE stock on March 4, 2020. The return on the trade was -2.30%.
What is Eddie Williams's role in Gyre Therapeutics?
Eddie Williams's role in Gyre Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.